Electroanalysis of sars-cov-2 specific igg and igm antibodies at microfluidic paper-based devices
dc.contributor.advisor | Pokpas, Keagan | |
dc.contributor.author | Du Plooy, Jarid | |
dc.date.accessioned | 2023-02-20T07:25:10Z | |
dc.date.accessioned | 2024-05-09T10:51:09Z | |
dc.date.available | 2024-05-09T10:51:09Z | |
dc.date.issued | 2022 | |
dc.description | >Magister Scientiae - MSc | en_US |
dc.description.abstract | The Covid-19 pandemic has taken the world by storm. The infectious disease, SARS-CoV-2, was caused by a newly found virus of the corona family. With over 6 million deaths worldwide, it is evident that the SARS-CoV-2 virus is deadly. This has placed world-wide health sectors under strain, working tirelessly toward effective vaccinations, treatments and monitoring. Further research into development of more rapid, low-cost, sensitive and reliable point-of-care (POC) SARS-CoV-2 devices is required to meet the needs of developing regions and tailor vaccine antibody production to prevent further spread of the disease. Moreover, carbon-based nanostructured materials have shown to improve biosensor detection capabilities with increased electron-transfer kinetics and active surface area resulting in more effective immobilizations of antibody/antigen onto modified electrodes surface. | en_US |
dc.description.embargo | 2026 | |
dc.identifier.uri | https://hdl.handle.net/10566/14583 | |
dc.language.iso | en | en_US |
dc.publisher | University of the Western Cape | en_US |
dc.rights.holder | University of the Western Cape | en_US |
dc.subject | Severe Acute Respiratory Syndrome Coronavirus 2 | en_US |
dc.subject | Covid-19 | en_US |
dc.subject | Public health | en_US |
dc.subject | Chemistry | en_US |
dc.title | Electroanalysis of sars-cov-2 specific igg and igm antibodies at microfluidic paper-based devices | en_US |